FDA Warning Wire: Lawsuit Targets Defiant Compounder
The U.S. Food and Drug Administration kicked off 2016 in rousing style this week by suing a Texas drug compounder that challenged the agency's inspection authority, questioning India-based Cadila Healthcare's drug...To view the full article, register now.
Already a subscriber? Click here to view full article